Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Brain Injury and Ketamine: a Prospective, Randomized Controlled Double Blind Clinical Trial to Study the Effects of Ketamine on Sedative Sparing and Intracranial Pressure in Traumatic Brain Injury Patients.


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05097261

Organisation Name: KU Leuven

Overal Status: Recruiting

Start Date: September 6, 2021

Last Update: October 28, 2021

Lead Sponsor: Geert Meyfroidt, MD, PhD

Brief Summary: Although, in the past years, an increasing use of ketamine in Traumatic Brain injury (TBI) has been reported as an adjunct to other sedatives, there is no evidence from randomized clinical trial to support this practice.

The BIKe (Brain Injury and Ketamine) study is a double-blind placebo controlled randomized multicenter clinical trial to examine the safety and feasibility of using ketamine as an adjunct to a standard sedative strategy in TBI patients.

Conditions:
  • Brain Injuries, Traumatic


Total execution time in seconds: 0.25652194023132